Poma, A.M.; Bruno, R.; Pietrini, I.; Alì, G.; Pasquini, G.; Proietti, A.; Vasile, E.; Cappelli, S.; Chella, A.; Fontanini, G.
Biomarkers and Gene Signatures to Predict Durable Response to Pembrolizumab in Non-Small Cell Lung Cancer. Cancers 2021, 13, 3828.
https://doi.org/10.3390/cancers13153828
AMA Style
Poma AM, Bruno R, Pietrini I, Alì G, Pasquini G, Proietti A, Vasile E, Cappelli S, Chella A, Fontanini G.
Biomarkers and Gene Signatures to Predict Durable Response to Pembrolizumab in Non-Small Cell Lung Cancer. Cancers. 2021; 13(15):3828.
https://doi.org/10.3390/cancers13153828
Chicago/Turabian Style
Poma, Anello Marcello, Rossella Bruno, Iacopo Pietrini, Greta Alì, Giulia Pasquini, Agnese Proietti, Enrico Vasile, Sabrina Cappelli, Antonio Chella, and Gabriella Fontanini.
2021. "Biomarkers and Gene Signatures to Predict Durable Response to Pembrolizumab in Non-Small Cell Lung Cancer" Cancers 13, no. 15: 3828.
https://doi.org/10.3390/cancers13153828
APA Style
Poma, A. M., Bruno, R., Pietrini, I., Alì, G., Pasquini, G., Proietti, A., Vasile, E., Cappelli, S., Chella, A., & Fontanini, G.
(2021). Biomarkers and Gene Signatures to Predict Durable Response to Pembrolizumab in Non-Small Cell Lung Cancer. Cancers, 13(15), 3828.
https://doi.org/10.3390/cancers13153828